A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine

Get answers to your Non-Hodgkin's lymphoma questions.
Dr. Kimball’s Bio | Q&A Archive
Lymphoma - non-Hodgkin's; Lymphocytic lymphoma; Histiocytic lymphoma; Lymphoblastic lymphoma; Cancer - non-Hodgkin's lymphoma
Treatment depends on:
Radiation therapy may be used for disease that is confined to one body area.
Chemotherapy is the main type of treatment. Most often,multiple different drugs are used in combination together.
Another drug, called rituximab (Rituxan), is often used to treat B-cell non-Hodgkin's lymphoma.
Radioimmunotherapy may be used in some cases. This involves linking a radioactive substance to an antibody that targets the cancerous cells and injecting the substance into the body.
People with lymphoma that returns after treatment or does not respond to treatment may receive high-dose chemotherapy followed by an autologous bone marrow transplant (using stem cells from yourself).
Additional treatments depend on other symptoms. They may include:
The stress of illness may be eased by joining a support group whose members share common experiences and problems.
Low-grade non-Hodgkin's lymphoma usually cannot be cured by chemotherapy alone. However, the low-grade form of this cancer progresses slowly, and it may take many years before the disease gets worse or even requires any treatment.
Chemotherapy can often cure many types of high-grade lymphoma. However, if the cancer does not respond to chemotherapy drugs, the disease can cause rapid death.
Call your health care provider if you develop symptoms of this disorder.
If you have non-Hodgkin's lymphoma, call your health care provider if you experience persistent fever or other signs of infection.
Bierman PJ, Harris N, Armitage JO. Non-Hodgkin’s lymphoma. In: Goldman L, Ausiello D, eds. Cecil Textbook of Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007: chap 196.
Wilson WH, Armitage JO. Non-Hodgkin’s Lymphoma. In: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG, eds. Abeloff’s Clinical Oncology. 4th ed. Philadelphia, Pa: Elsevier Churchill Livingstone; 2008:chap 112.
National Comprehensive Cancer Network. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Non-Hodgkin’s Lymphomas. 2011. Version 1.2011.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885